Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Quaker BioVentures

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 58
Average round size
The average size of a deal this fund participated in
Portfolio companies 36
Rounds per year 2.90
Lead investments 12
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 19
Key employees 13
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics

Quaker BioVentures is the famous VC, which was founded in 2002. The main department of described VC is located in the Philadelphia. The venture was found in North America in United States.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Quaker BioVentures, startups are often financed by Domain Associates, Investor Growth Capital Limited, Three Arch Partners. The meaningful sponsors for the fund in investment in the same round are Johnson & Johnson Development Corporation, Intersouth Partners, Investor Growth Capital Limited. In the next rounds fund is usually obtained by Johnson & Johnson Development Corporation, Investor Growth Capital Limited, Domain Associates.

Besides them, we counted 13 critical employees of this fund in our database.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Celator Pharmaceuticals, Rapid Micro Biosystems, TetraLogic Pharmaceuticals Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Health Diagnostics.

The higher amount of exits for fund were in 2017. The high activity for fund was in 2007. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 8 percentage points more often commits exit comparing to other organizations. This Quaker BioVentures works on 1 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Quaker BioVentures:
Typical Co-investors
Quaker BioVentures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Quaker BioVentures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Capital Development Investment Fund Beijing, Beijing, China
Dongling Yuda Capital - Beijing, Beijing, China
Groupe Richbond -
Huaxinke Intelligent Manufacturing Technology China, Guangdong, Guangzhou
Jupiter Telecommunications (J:COM) Japan, Tokyo
NN Group The Hague, The Netherlands, Zuid-Holland
NOMO Ventures California, San Francisco, United States
Rive Private Investment Geneva, Geneve, Switzerland
Shenzhen Qianhai Jiayang Venture Capital China, Guangdong, Shenzhen
Shenzhen Tasen Touzi Konggu Co., Ltd. China, Guangdong, Shenzhen
Social Family Group Australia, New South Wales, North Sydney
South River Capital China, Shanghai
StudiVZ Berlin, Berlin, Germany
Teca Partners New York, New York, United States
Trilogy Equity Partners Bellevue, United States, Washington
Watchfire Ventures California, Santa Barbara, United States
Zhongguo Jiankang Chanye Touzi Jijin Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


3D Technology
Autonomous Vehicles
Civil Engineering
Location Based Services
Mapping Services
Real Time
$6M20 Mar 2019 Pittsburgh, Pennsylvania, United States


Health Care
Medical Device
$34M27 Apr 2015 Pennsylvania, United States

PreCision Dermatology

Health Care
$67M23 Sep 2013 Rhode Island, United States

RainDance Technologies

Health Care
Health Diagnostics
$20M29 Apr 2013 Massachusetts, United States

Intact Vascular

Health Care
Medical Device
$15M05 Sep 2012 Radnor Township, Pennsylvania, United States

Tarsa Therapeutics

Medical Device
$28M16 Mar 2012 Philadelphia, Pennsylvania, United States


Medical Device
$35M27 Jun 2011 Maryland, United States


Health Care
Medical Device
$30M16 May 2011 Pennsylvania, United States

RainDance Technologies

Health Care
Health Diagnostics
$37M25 Jan 2011 Massachusetts, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Quaker BioVentures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: